Literature DB >> 28456663

Comparative whole genome analysis of dengue virus serotype-2 strains differing in trans-endothelial cell leakage induction in vitro.

Sneha Singh1, M G Anupriya1, Easwaran Sreekumar2.   

Abstract

The role of genetic differences among dengue virus (DENV) in causing increased microvascular permeability is less explored. In the present study, we compared two closely related DENV serotype-2 strains of Cosmopolitan genotype for their in vitro infectivity phenotype and ability to induce trans-endothelial leakage. We found that these laboratory strains differed significantly in infecting human microvascular endothelial cells (HMEC-1) and hepatocytes (Huh7), two major target cells of DENV in in vivo infections. There was a reciprocal correlation in infectivity and vascular leakage induced by these strains, with the less infective strain inducing more trans-endothelial cell leakage in HMEC-1 monolayer upon infection. The cells infected with the strain capable of inducing more permeability were found to secrete more Non-Structural protein (sNS1) into the culture supernatant. A whole genome analysis revealed 37 predicted amino acid changes and changes in the secondary structure of 3' non-translated region between the strains. But none of these changes involved the signal sequence coded by the C-terminal of the Envelope protein and the two glycosylation sites within the NS1 protein critical for its secretion, and the N-terminal NS2A sequence important for surface targeting of NS1. The strain that secreted lower levels of NS1 and caused less leakage had two mutations within the NS1 protein coding region, F103S and T146I that significantly changed amino acid properties. A comparison of the sequences of the two strains with published sequences of various DENV strains known to cause clinically severe dengue identified a number of amino acid changes which could be implicated as possible key genetic differences. Our data supports the earlier observations that the vascular leakage induction potential of DENV strains is linked to the sNS1 levels. The results also indicate that viral genetic determinants, especially the mutations within the NS1 coding region, could affect this critical phenotype of DENV strains.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dengue virus serotype 2; Endothelial cells; Genetic changes; Hepatocytes; Infectivity; Secretory NS1; Vascular leakage

Mesh:

Substances:

Year:  2017        PMID: 28456663     DOI: 10.1016/j.meegid.2017.04.022

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  3 in total

1.  Subsets of Cytokines and Chemokines from DENV-4-Infected Patients Could Regulate the Endothelial Integrity of Cultured Microvascular Endothelial Cells.

Authors:  Marcio da Costa Cipitelli; Iury Amancio Paiva; Jéssica Badolato-Corrêa; Cíntia Ferreira Marinho; Victor Edgar Fiestas Solórzano; Nieli Rodrigues da Costa Faria; Elzinandes Leal de Azeredo; Luiz José de Souza; Rivaldo Venâncio da Cunha; Luzia Maria de-Oliveira-Pinto
Journal:  Pathogens       Date:  2022-04-26

2.  Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences.

Authors:  Arun Sankaradoss; Suraj Jagtap; Junaid Nazir; Shefta E Moula; Ayan Modak; Joshuah Fialho; Meenakshi Iyer; Jayanthi S Shastri; Mary Dias; Ravisekhar Gadepalli; Alisha Aggarwal; Manoj Vedpathak; Sachee Agrawal; Awadhesh Pandit; Amul Nisheetha; Anuj Kumar; Mahasweta Bordoloi; Mohamed Shafi; Bhagyashree Shelar; Swathi S Balachandra; Tina Damodar; Moses Muia Masika; Patrick Mwaura; Omu Anzala; Kar Muthumani; Ramanathan Sowdhamini; Guruprasad R Medigeshi; Rahul Roy; Chitra Pattabiraman; Sudhir Krishna; Easwaran Sreekumar
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 12.910

3.  Componential usage patterns in dengue 4 viruses reveal their better evolutionary adaptation to humans.

Authors:  Gun Li; Liang Shi; Liang Zhang; Bingyi Xu
Journal:  Front Microbiol       Date:  2022-09-20       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.